Twist Bioscience宣布将于2026年8月3日披露2026财年三季报

Skip to main navigation

en

Investor Relations

Investors

Overview

Stock

Stock Quote & Chart

Analyst Coverage

Analyst Estimates

News & Events

Press Releases

Investor Calendar

Presentations

Financials

SEC Filings

Annual Reports

Governance

Governance Highlights

Committee Composition

Resources

Email Alerts

IR Contacts

Press Release Details

Twist Bioscience to Report Fiscal 2026 Third Quarter Financial Results on Monday, August 3, 2026

Jul 15, 2026

PDF Version

Company to host conference call at 8:00 AM ET

SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Jul. 15, 2026-- Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that it will issue its financial results for the fiscal 2026 third quarter ended June 30, 2026 , before the opening of the market on August 3, 2026 . The company plans to hold a conference call and live audio webcast for analysts and investors at 8:00 a.m. Eastern Time to discuss its financial results and provide an update on the company’s business. The press release with the financial results will be accessible from the company’s website prior to the conference call through the Investor Relations section under the “Company” tab at www.twistbioscience.com .

The conference call will be webcast live through the Investor Relations section under the “Company” tab at www.twistbioscience.com . Those parties interested in participating via telephone must register on the Company’s Investor Relations website or by clicking here . Upon registration, all telephone participants will receive the dial-in number along with a unique PIN number that can be used to access the call. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. The webcast replay will be available for two weeks.

About Twist Bioscience Corporation

At Twist Bioscience, our customizable solutions across the biological continuum raise the bar in diagnostics, therapeutics, industrial, agriculture and research markets.

We drive innovation with confidence, without compromise. Whether delivering oligos, genes, proteins, libraries, characterization data, antibody discovery solutions, or NGS workflow tools, our scientific expertise and exceptional customer experience help navigate complex challenges, all with precision and at the scale and speed customers require. By enhancing R&D efficiency at every turn, we give scientists more shots on goal – more experiments, more iterations, more chances for remarkable discoveries.

Together, we stand with customers in the relentless pursuit of progress, backed by enterprise reliability, to shape a healthier and more sustainable future for all. For more information about our products and services, please visit www.twistbioscience.com .

Follow us on LinkedIn | X | YouTube | Instagram | Bluesky

View source version on businesswire.com: https://www.businesswire.com/news/home/20260715904870/en/

For Investors:
Angela Bitting
SVP, Corporate Affairs
925-202-6211
abitting@twistbioscience.com

For Media:
Amanda Houlihan
Communications Manager
774-265-5334
ahoulihan@twistbioscience.com

Source: Twist Bioscience Corporation

Print Page

Email Page

Email Alerts

RSS Feeds

Quick Links

Twist Bioscience HQ

681 Gateway Blvd

South San Francisco, CA 94080

The figures contained in the analyst consensus tables are a simple arithmetic average of the most recent forecasts that have been provided to Twist. The figures do not give greater weight to more recent forecasts or to the forecasts of any individual analyst.
Moreover, the data has not been adjusted to exclude any submission.
The information is provided purely for convenience to users of our website, for information purposes only. This information is, by definition, forward-looking and is therefore subject to various risks and uncertainties which are subject to change at any time and may materially affect actual results or performance.
The consensus data is based on the analysts' opinions, forecasts, estimates, projections and predictions regarding Twist's performance.
It does not represent Twist's own views on its performance nor does Twist endorse or concur with any of such analysts’ opinions, estimates, forecasts or recommendations. Twist has not verified any of the information it has received and none of Twist, its affiliates or their respective directors, officers and employees make any representation or warranty, express or implied, as to, or accept any responsibility for, the accuracy or completeness of the consensus information. Twist does not assume any responsibility to update, revise or supplement such information.
The consensus data was last updated on November 20, 2025.
Continue